A human thyroid cancer cell line, DH-14-3, newly established from poorly differentiated thyroid carcinoma

Jin Teshima, Hideyuki Doi, Keisei Fujimori, Michio Watanabe, Noriaki Nakajima, Tomoyuki Nakano, Yoshio Takahashi, Noriaki Ohuchi, Susumu Satomi

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Poorly differentiated thyroid carcinoma (PDTC) is a newly recognized histological type of malignant thyroid tumor, accounting for about 2 - 13% of all thyroid carcinomas. PDTC is considered as a morphologically and biologically intermediate stage between well-differentiated thyroid carcinoma and anaplastic thyroid carcinoma. PDTC preferentially manifests bone metastases. We here established a cell line from a resected tumor specimen from a 70-year-old male patient with PDTC who presented with multiple bone metastases. This new thyroid tumor cell line was designated as DH-14-3 and was subsequently grown in culture for several years. DH-14-3 cells express thyroglobulin in the cytoplasm and thyroid transcription factor-1 in the nuclei, both proteins of which are specific markers for the thyroid gland. Importantly, triiodothyronine (T3) was detected in the cultured medium of DH-14-3 cells, in which, however, thyroxine (T4) was undetectable. Moreover, DH-14-3 cells secreted interleukin-8, transforming growth factor-β 1, vascular endothelial growth factor, matrix metalloproteinase-1 and parathyroid hormone-related protein, all of which may be responsible for the aggressiveness or bone metastasis of PDTC. Thus, the production of these proteins may reflect the metastatic potential of this cell line. DH-14-3 cells also express CXC chemokine receptor-4 and epidermal growth factor receptor, and carry a missense mutation in the p53 tumor suppressor gene. In fact, transplantation of DH-14-3 cells into the back of nude mice resulted in the formation of tumors, thereby confirming the capability of tumorigenesis. DH-14-3 cells may be useful for investigating the biological features of PDTC and will contribute to the therapeutic study of thyroid cancer.

Original languageEnglish
Pages (from-to)75-82
Number of pages8
JournalTohoku Journal of Experimental Medicine
Issue number2
Publication statusPublished - 2013


  • Bone metastasis
  • Interleukin-8
  • Poorly differentiated thyroid carcinoma
  • Thyroid hormone
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'A human thyroid cancer cell line, DH-14-3, newly established from poorly differentiated thyroid carcinoma'. Together they form a unique fingerprint.

Cite this